Skip to main content
SpringerLink
Log in

Surgery for Stress Urinary Incontinence: Minimally Invasive Procedures

  • Chapter
Continence

  • 839 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Murless BC. 1938; The injection treatment of stress incontinence. J Obstet Gynecol Br Emp 45:521–524.

    Google Scholar 

  2. Quackels R. 1955; Deux incontinence apr; ages adenonectomie: Queries par injection de paraffine dans la perin; aaee. Acta Urol Belg 23:259–262.

    PubMed  CAS  Google Scholar 

  3. Sachse H. 1963; Treatment of urinary incontinence with sclerosing solutions: Indications, results, complications. Urol Int 15:225–244.

    Article  PubMed  CAS  Google Scholar 

  4. Dmochowski RR, Appell RA. 2000; Injectable agents in the treatment of stress urinary incontinence in women: Where are we now? Urology 56:(Suppl 6A)32–40.

    Article  PubMed  CAS  Google Scholar 

  5. Crystle CD, Charme LS, Copeland WE. 1971; Q-tip test in stress urinary incontinence. Obstet Gynecol 39:313–315.

    Google Scholar 

  6. Appell RA, Ostergard D. 1992; Practical urodynamics. Illustr Med Female Urol Ser 2:4–29.

    Google Scholar 

  7. Kreder KJ, Austin JC. 1996; Treatment of stress urinary incontinence in women with urethral hypermobility and intrinsic sphincter deficiency. J Urol 156:1995–198.

    Article  PubMed  CAS  Google Scholar 

  8. Smith DN, Appell RA, Winters JC,. et al. 1997; Collagen injection therapy for female intrinsic sphincter deficiency. J Urol 152:1275–1278.

    Google Scholar 

  9. Herschorn S, Radomski SB, Steele DJ. 1992; Early experience with intraurethral collagen injection for urinary incontinence. J Urol 148:1797–1800.

    PubMed  CAS  Google Scholar 

  10. Herschorn S, Radomski SB. 1997; Collagen injections for genuine stress urinary incontinence: Patient selection and durability. Int Urogynecol J 8:18–24.

    Article  CAS  Google Scholar 

  11. Faerber GJ. 1995; Endoscopic collagen injection therapy for elderly women with type I stress urinary incontinence. J Urol 153:527A.

    Article  Google Scholar 

  12. Winters J, Chiverton A, Scarpero H,. et al. 2000; Collagen injection therapy in elderly women: Long-term results and patient satisfaction. Urology 55:815–818.

    Google Scholar 

  13. Steele AC, Kohli N, Karram MM. 2000; Periurethral collagen injection for stress incontinence with and without urethral hypermobility. Obstet Gynecol 95:322–331.

    Article  Google Scholar 

  14. Bent, AE, Foote, J, Siegel S,. et al. 2001; Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol 166:(4)1354–1357.

    Article  PubMed  CAS  Google Scholar 

  15. Winters JC. 2004; Urodynamics in the era of tension-free slings. Curr Urol Rep 5:(5)343–347.

    Article  PubMed  Google Scholar 

  16. O’Connell HE, McGuire EJ. 1995; Transurethral collagen therapy in women. J Urol 154:1463–1465.

    Article  PubMed  Google Scholar 

  17. Appell RA. 1990; Injectables for urethral incompetence. World J Urol 8:208–211.

    Article  Google Scholar 

  18. Appell RA. 1994.The periurethral injection of autologous blood. Presented at the American Urogynecologic Society annual meeting, Toronto,

    Google Scholar 

  19. Neal ED Jr Lahaye ME, Lowe DC. 1995; Improved needle placement technique in periurethral collagen injection. Urology 45:865–866.

    Article  PubMed  Google Scholar 

  20. Faerber GJ, Belville WD, Ohl DA,. et al. 1998; Comparison of transurethral versus periurethral collagen injection in women with intrinsic sphincter deficiency. Tech Urol 4:(3)124–127.

    PubMed  CAS  Google Scholar 

  21. Schulz JA, Nager CW, Stanton SL,. et al. 2004; Bulking agents for stress urinary incontinence: Short-term results and complications in a randomized comparison of periurethral and transurethral injection. Int Urogynecol J Pelvic Floor Dysfunct 15:261–265.

    PubMed  Google Scholar 

  22. Appell RA. 1996: Collagen injections. In: Raz S, ed. Female urology. 2nd ed. WB Saunders, Philadelphia: 399–405.

    Google Scholar 

  23. Defreitas GA, Wilson TS, Zimmern PE,. et al. 2003; Three-dimensional ultrasonography: An objective outcome to assess collagen distribution in women with stress urinary incontinence. Urology 62:232–236.

    Article  PubMed  Google Scholar 

  24. Poon CI, Zimmern PE, Defreitas GA,. et al. 2005; Three-dimensional ultrasonography to assess long-term durability of periurethral collagen in women with stress urinary incontinence due to intrinsic sphincteric deficiency. Urology 65:60–64.

    Article  PubMed  Google Scholar 

  25. Cross CA, English SF, Cespedes RD,. et al. 1998; A follow-up on transurethral collagen injection therapy for urinary incontinence. J Urol 159:106–108.

    Article  PubMed  CAS  Google Scholar 

  26. Stothers L, Goldenberg SL, Leone EF. 1998; Complications of periurethral collagen injection for stress urinary incontinence. J Urol 159:(3)806–807.

    Article  PubMed  CAS  Google Scholar 

  27. Bergman A, Koonings PP, Ballard CA. 1990; Negative Q-tip test as a risk factor for failed incontinence surgery in women. J Reprod Med 34:(3)193–197.

    Google Scholar 

  28. Segal JL, Vasallo BJ, Kleeman SD,. et al. 2006; The efficacy of tension-free vaginal tape in the treatment of five subtypes of stress urinary incontinence. Int J Pelvic Floor Dysfunct 17:(2)120–124.

    Article  Google Scholar 

  29. Gonzalez de Garibay AS, Castro-Morrondo JM, Castro-Jimeno JM. 1989; Endoscopic injection of autologous adipose tissue in the treatment of female incontinence. Arch Esp Urol 42:143–146.

    Google Scholar 

  30. Gonzalez de Garibay AS, Castillo-Jimeno JM, Villanueva-Perez PI. 1991; Treatment of urinary stress incontinence using paraurethral injection of autologous fat. Arch Esp Urol 44:595–600.

    PubMed  CAS  Google Scholar 

  31. Santarosa RP, Blaivas JG. 1994; Periurethral injection of autologous fat for the treatment of sphincteric incontinence. J Urol 151:607–611.

    PubMed  CAS  Google Scholar 

  32. Blaivas JG, Herwitz D, Santarosa RP, et al. 1994; Periurethral fat injection for sphincteric incontinence in women. J Urol 151:419A.

    Google Scholar 

  33. Lee PE, Kung RC, Drutz HP. 2000; Periurethral autologous fat injection as treatment for female stress urinary incontinence: A randomized double-blind controlled trial. J Urol 165: 153–158.

    Article  Google Scholar 

  34. Bartynski J, Marion MS, Wang TD. 1990; Histopathologic evaluation of adipose autografts in a rabbit ear model. Otolaryngology 102:314.

    CAS  Google Scholar 

  35. Sweat SD, Lightner DJ. 1999; Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents. J Urol 161:93–96.

    Article  PubMed  CAS  Google Scholar 

  36. Moalli PA, Shand SH, Zyczynski HM,. et al. 2005; Remodeling of vaginal connective tissue in patients with pelvic organ prolpase. Obstet Gynecol 106:(5 Pt 1)953–963.

    Article  PubMed  Google Scholar 

  37. DeLustro F, Dasch J, Keefe J,. et al. 1990; Immune response to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin Orthop 260:263–279.

    PubMed  Google Scholar 

  38. McPherson JM, Sawamura S, Armstrong R. 1986; An examination of the biologic response to injectable glutaraldehyde cross-linked collagen implants. J Biomed Matter Res 20:93–97.

    Article  CAS  Google Scholar 

  39. DeLustro F, Keefe J, Fong AT,. et al. 1991; The biochemistry, biology, and immunology of injectable collagens: Contigen Bard collagen implant in treatment of urinary incontinence. Pediatr Surg Int 6:245–251.

    Article  Google Scholar 

  40. Canning DA, Peters CA, Gearhart JR,. et al. 1988; Local tissue reaction to glutaraldehyde cross-linked bovine collagen in the rabbit bladder. J Urol 139:258–259.

    Google Scholar 

  41. Remacle M, Marbaix E. 1988; Collagen implants in the human larynx. Arch Otorhinolaryngol 245:203–209.

    Article  PubMed  CAS  Google Scholar 

  42. Appell RA. 1994; Collagen injection therapy for urinary incontinence. Urol Clin North Am 21:177–182.

    PubMed  CAS  Google Scholar 

  43. Appell RA. 1990; New developments: Injectables for urethral incompetence in women. Int Urogynecol J 1:117–119.

    Article  Google Scholar 

  44. Appell RA, McGuire EJ, DeRidder PA, et al. 1994; Summary of effectiveness and safety in the prospective, open, multicenter investigation of Contigen implant for incontinence due to intrinsic sphincteric deficiency in females. J Urol 151:418A.

    Google Scholar 

  45. Striker P, Haylen B. 1993; Injectable collagen for type 3 female stress incontinence: The first 50 Australian patients. Med J Aust 158:89–91.

    Google Scholar 

  46. Swami SK, Eckford SD, Abrams P. 1994; Collagen injections for female stress incontinence: Conclusions of a multistage analysis and results. J Urol 151:479A.

    Google Scholar 

  47. Appell RA. 1992; Use of collagen injections for treatment of incontinence and reflux. Adv Urol 5:145–165.

    Google Scholar 

  48. Richardson TD, Kennelly MJ, Faerber GJ. 1995; Endoscopic injection of glutaraldehyde cross-linked collagen for the treatment of intrinsic sphincteric deficiency in women. Urology 46:378–381.

    Article  PubMed  CAS  Google Scholar 

  49. Corcos J, Fournier C. 1999; Periurethral collagen injection for the treatment of female stress urinary incontinence: 4-year follow-up results. Urology 54:815–818.

    Article  PubMed  CAS  Google Scholar 

  50. Gorton E, Stanton S, Monga A,. et al. 1999; Periurethral collagen injection: A long-term follow-up study. BJU Int 84:966–971.

    Article  PubMed  CAS  Google Scholar 

  51. Bard CR, Inc. PMAA submission to United States Food and Drug Administration for IDE G850010, 1990.

    Google Scholar 

  52. Ford CN, Martin CW, Warren TF. 1984; Injectable collagen in laryngeal rehabilitation. Laryngoscope 95:513–518.

    Article  Google Scholar 

  53. Stegman S, Chu S, Bensch K,. et al. 1987; A light and electron microscopic evaluation of Zyderm and Zyplast implants in aging human facial skin: A pilot study. Arch Dermatol 123:1644–1649.

    Article  PubMed  CAS  Google Scholar 

  54. DeLustro F, Condell RA, Nguyen MA,. et al. 1986; A comparative study of the biologic and immunologic response to medical devices derived from dermal collagen. J Biomed Mater Res 20:109–120.

    Article  PubMed  CAS  Google Scholar 

  55. McLennan MT, Bent AE. 1998; Suburethral abscess: A complication of periurethral collagen injection therapy. Obstet Gynecol 92:650–652.

    Article  PubMed  CAS  Google Scholar 

  56. Stothers L, Goldenberg SL. 1998; Delayed hypersensitivity and systemic arthralgia following transurethral collagen injection for stress urinary incontinence. J Urol 159:1507–1509.

    Article  PubMed  CAS  Google Scholar 

  57. Berg S. 1973; Polytef augmentation urethroplasty: Correction of surgically incurable urinary incontinence by injection technique. Arch Surg 107:379–381.

    PubMed  CAS  Google Scholar 

  58. Politano VA, Small MP, Harper JM,. et al. 1974; Periurethral Teflon injection for urinary incontinence. J Urol 111:180–183.

    PubMed  CAS  Google Scholar 

  59. Heer H. 1977; Die Behandlung der Harnin-kontinenz mit der Teflon-paste. Urol Int 32:295–302.

    Article  PubMed  CAS  Google Scholar 

  60. Lampante L, Kaesler FP, Sparwasser H. 1979; Endourethrale submukose Tefloninjektion zur Erzielung von Harninkontinenz. Akt Urol 10:265–272.

    Google Scholar 

  61. Lim KB, Ball AJ, Feneley RCL. 1983; Periurethral Teflon injection: A simple treatment for urinary incontinence. Br J Urol 55:208–210.

    Article  PubMed  CAS  Google Scholar 

  62. Schulman CC, Simon J, Wespes E,. et al. 1983; Endoscopic injection of Teflon for female urinary incontinence. Eur Urol 9:246–247.

    PubMed  CAS  Google Scholar 

  63. Deane AM, English P, Hehir M,. et al. 1985; Teflon injection in stress incontinence. Br J Urol 57:78–80.

    Article  PubMed  CAS  Google Scholar 

  64. Appell RA. 1990:Commentary: Periurethral polytetrafluoroethylene (Polytef) injection. In: Whitehead ED, ed. Current operative urology. JB Lippincott, Philadelphia: 63–66.

    Google Scholar 

  65. Cole HM. 1993; Diagnostic and therapeutic technology assessment (DATTA). JAMA 269:2975–2980.

    Article  Google Scholar 

  66. Buckley JF, Lingham K, Meddings RN, et al. 1993; Injectable Teflon paste for female stress incontinence: Long-term follow-up and results. J Urol 149:418A.

    Google Scholar 

  67. Politano VA. 1982; Periurethral polytetrafluoroethylene injection for urinary incontinence. J Urol 127:439–442.

    PubMed  CAS  Google Scholar 

  68. Stone JW, Arnold GE. 1967; Human larynx injected with Teflon paste: Histologic study of innervation and tissue reaction. Arch Otolaryngol 86:550–562.

    PubMed  CAS  Google Scholar 

  69. Politano VA. 1978; Periurethral Teflon injection for urinary incontinence. Urol Clin North Am 5:415–422.

    PubMed  CAS  Google Scholar 

  70. Malizia AA Jr, Reiman JM, Myers RP,. et al. 1984; Migration and granulomatous reaction after periurethral injection of Polytef (Teflon). JAMA 251:3277–3281.

    Article  PubMed  Google Scholar 

  71. Vandenbossche M, Delhobe O, Dumortier P,. et al. 1994; Endoscopic treatment of reflux: Experimental study and review of Teflon and collagen. Eur Urol 23:386.

    Google Scholar 

  72. Mittleman RE, Marraccini JV. 1983; Pulmonary Teflon granulomas following periurethral Teflon injection for urinary incontinence. Arch Pathol Lab Med 107:611–612.

    PubMed  CAS  Google Scholar 

  73. Claes H, Stroobants D, van Meerbeek J,. et al. 1989; Pulmonary migration following periurethral polytetrafluoroethylene injection for urinary incontinence. J Urol 142:821–822.

    PubMed  CAS  Google Scholar 

  74. Sanfilippo F, Shelburne J, Ingram P. 1980; Analysis of a Polytef granuloma mimicking a cold thyroid nodule 17 months after laryngeal injection. Ultrastruct Pathol 1:471–475.

    Article  PubMed  CAS  Google Scholar 

  75. Oppenheimer BS, Oppenheimer ET, Stout AP,. et al. 1958; The latent period in carcinogenesis by plastics in rats and its relation to the presarcomatous stage. Cancer 11:204–213.

    Article  PubMed  CAS  Google Scholar 

  76. Hakky M, Kolbusz R, Reyes CV. 1989; Chondrosarcoma of the larynx. Ear Nose Throat J 68:60–62.

    PubMed  CAS  Google Scholar 

  77. Lewy RB. 1976; Experience with vocal cord injection. Ann Otol Rhinol Laryngol 85:440–450.

    PubMed  CAS  Google Scholar 

  78. Montgomery WW. 1979; Laryngeal paralysis – Teflon injection. Ann Otol 88:647–657.

    CAS  Google Scholar 

  79. Dewan PA. 1992; Is injected polytetrafluoroethylene (Polytef) carcinogenic? Br J Urol 69:29–33.

    Article  PubMed  CAS  Google Scholar 

  80. Dewan PA, Owen AJ, Byard RW. 1995; Long-term histological response to subcutaneously injected Polytef and Bioplastique in a rat model. Br J Urol 76:(2)161–164.

    Article  PubMed  CAS  Google Scholar 

  81. Buckley JF, Scott R, Meddings, et al. 1992; Injectable silicone microparticles: A new treatment for female stress incontinence. J Urol 147:280A.

    Google Scholar 

  82. Buckley JF, Lingham K, Lloyd SN, et al. 1993; Injectable silicone macroparticles for female urinary incontinence. J Urol 149:402A.

    Google Scholar 

  83. Radley SC, Chapple CR, MItsogiannis IC,. et al. 2001; Transurethral implantation of Macroplastique for the treatment of female stress urinary incontinence secondary to intrinsic sphincteric deficiency. Eur Urol 39:383–389.

    Article  PubMed  CAS  Google Scholar 

  84. Tamanini JT, D’Ancona CA, Tadini V,. et al. 2003; Macroplastique implantation system for female stress urinary incontinence. J Urol 169:2229–2233.

    Article  PubMed  Google Scholar 

  85. Anders K, Khullar V, Cardozo L,. et al. 1999; Gax-collagen or Macroplastique. Does it make a difference? Neururol Urodyn 18:297–298.

    Google Scholar 

  86. Ter Meulen PH, Berghmans LC, van Kerrebroeck PE. 2003; Systematic review: Efficacy of silicone microimplants (Macroplastique) therapy for stress urinary incontinence in adult women. Eur Urol 44:573–582.

    Article  PubMed  Google Scholar 

  87. Henly DR, Barrett DM, Weiland TL,. et al. 1995; Particulate silicone for use in periurethral injections: Local tissue effects and search for migration. J Urol 153:2039–2043.

    Article  PubMed  CAS  Google Scholar 

  88. Lightner D, Calvosa C, Andersen R,. et al. 2001; A new injectable bulking agent for treatment of stress urinary incontinence: Results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology 58:12–15.

    Article  PubMed  CAS  Google Scholar 

  89. Pannek J, Brands FH, Senge T. 2001; Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence. J Urol 166:1350–1353.

    Article  PubMed  CAS  Google Scholar 

  90. Madjar S, Covington-Nichols C, Secrest CL. 2003; New periurethral bulking agent for stress urinary incontinence: Modified technique and early results. J Urol 170:2327–2329.

    Article  PubMed  Google Scholar 

  91. Chrouser KL, Fick F, Goel A,. et al. 2004; Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincteric deficiency: Continence and satisfaction after extended follow-up. J Urol 171:1152–1155.

    Article  PubMed  CAS  Google Scholar 

  92. United States Food and Drug Administration: Durasphere™ Injectable Bulking Agent. Summary of Safety and Effectiveness Data, 1999. www.fda.gov/cdrh/pdf/p980053.html.

  93. Madjar S, Sharma AK, Waltzer WC,. et al. 2006; Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J Urol 175:1408–1410.

    Article  PubMed  CAS  Google Scholar 

  94. Ritts RE. 2002; Particle migration after transurethral injection of carbon coated beads. J Urol 167:1804–1805.

    Article  PubMed  CAS  Google Scholar 

  95. United States Food and Drug Administration. URYX® Urethral bulking agent – P030030 Part II: Summary of safety and effectiveness data, 2004. http://www.fda.gov/cdrh/PDF3/p030030b.

  96. Dmochowski RR, Appell RA. 2003; Advancements in minimally invasive treatments for female stress urinary incontinence: Radiofrequency and bulking agents. Curr Urol Rep 4:350–355.

    Article  PubMed  Google Scholar 

  97. Dmochowski RR. 2005; Tegress. ™ Urethral implant phase III clinical experience and product uniqueness Rev Urol,7:(Suppl 1)S22–26.

    Google Scholar 

  98. Hurtado EA, McCrery RJ, Appell RA. The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency. Int Urogynecol J 2007; 18; 869–73.

    Google Scholar 

  99. Hurtado EA, McCrery RJ, Appell RA. 2008; Complications of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in men with stress urinary incontinence. Urology 71:662–65.

    Article  PubMed  Google Scholar 

  100. Mayer R, Lightfoot M, Jung I. 2001; Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence. Urology 57:434–438.

    Article  PubMed  CAS  Google Scholar 

  101. United States Food and Drug Administration. Coaptite® implanted device. www.fda.gov/cdrh/mda/docs/p040047.html, 2005.

  102. Winters JC, Appell RA. 1995; Periurethral injection of collagen in the treatment of intrinsic sphincteric deficiency in the female patient. Urol Clin North Am 22:673–678.

    PubMed  CAS  Google Scholar 

  103. Biomatrix Corporation. Formal report of feasibility study of Hylagel Uro. Corporate white paper. Ridgefield, NJ, June 2000.

    Google Scholar 

  104. Stenberg A, Larsson G, Johnson P,. et al. 1999; DiHA Dextran copolymer, a new biocompatible material for endoscopic treatment of stress incontinent women. Acta Obstet Gynecol Scand 78:436–442.

    Article  PubMed  CAS  Google Scholar 

  105. Stenberg A, Larsson G, Johnson P. 2003; Urethral injection for stress urinary incontinence: Long-term results with dextranomer/hyaluronic acid copolymer. Int Urogynecol J Pelvic Dysfunct 14:335–338.

    Article  CAS  Google Scholar 

  106. Van Kerrebroeck P, ter Meulen F, Larsson G,. et al. 2004; Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence. Urology 64:276–281.

    Article  PubMed  Google Scholar 

  107. Walker RS, Wilson K, Clark AE. 1992; Injectable bioglass as a potential substitute for injectable polytetrafluorethylene. J Urol 148:645–647.

    PubMed  CAS  Google Scholar 

  108. Atala A, Cima LG, Kim W, et al. 1993; Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J Urol 150:745–747.

    PubMed  CAS  Google Scholar 

  109. Bent AE, Tutrone RT, McLennan, et al. 2001; Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent. Neurourol Urodyn 20:157–165.

    Article  PubMed  CAS  Google Scholar 

  110. Yokoyama T, Chancellor MB, Watanabe T,. et al. 2000; Primary myoblast injection into urethra and bladder as a potential treatment of stress urinary incontinence and impaired detrusor contractility: Long-term survival without significant cytotoxicity. J Urol 161:307.

    Google Scholar 

  111. Cannon TW, Lee JY, Somogyi G,. et al. 2003; Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra. Urology 62:958–963.

    Article  PubMed  Google Scholar 

  112. Peyromaure M, Sebe P, Praud C,. et al. 2004; Fate of implanted syngeneic muscle precursor cells in striated urethral sphincter of female rats: Perspectives for the treatment of urinary incontinence. Urology 64:1037–1041.

    Article  PubMed  Google Scholar 

  113. Pycha A, Klinger CH, Haitel A,. et al. 2000; 3 years experience with implantable microballoons for the treatment of intrinsic sphincter deficiency. J Urol 161:307.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Baylor College of Medicine, St. Luke’s Episcopal Hospital, Houston, TX, USA

    Eric A. Hurtado & Rodney A. Appell

Authors
  1. Eric A. Hurtado
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rodney A. Appell
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, Wake Forest University Baptist Medical Center, Winston Salem, NC, USA

    Gopal H. Badlani MD

  2. Department of Gynecology, Cleveland Clinic Florida, Weston, FL, USA

    G. Willy Davila MD

  3. Department of Pharmacology and Pharmacotherapy Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    Martin C. Michel MD, MAE

  4. Department of Urology Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    Jean J. M. C. H. de la Rosette MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Hurtado, E. ., Appell, R. . (2009). Surgery for Stress Urinary Incontinence: Minimally Invasive Procedures. In: Badlani, G.H., Davila, G.W., Michel, M.C., de la Rosette, J.J.M.C.H. (eds) Continence. Springer, London. https://doi.org/10.1007/978-1-84628-510-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-510-3_12

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-510-3

  • Online ISBN: 978-1-84628-734-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation